Taurine reduces nitrosative stress and nitric oxide synthase expression in high glucose-exposed human Schwann cells

The role of taurine in regulating glucose-induced nitrosative stress has been examined in human Schwann cells, a model for understanding the pathogenesis of diabetic neuropathy. Exposure to high glucose increased nitrated proteins (1.56 fold p < 0.05), inducible nitric oxide synthase (iNOS) and neuronal NOS (nNOS) mRNA expression (1.55 fold and 2.2 fold respectively, p < 0.05 both), phospho-p38 MAPK (1.32 fold, p < 0.05) abundance and decreased Schwann cell growth (11 ± 2%, p < 0.05). Taurine supplementation prevented high-glucose induced iNOS and nNOS mRNA upregulation, reduced nitrated proteins and phospho-p38 MAPK (56 ± 11% and 45 ± 18% (p < 0.05 both) respectively) and restored Schwann cell growth to control levels. High glucose and taurine treatment alone reduced phospho-p42/44 MAPK and phospho-AKT to below detectable levels. Treatment of human Schwann cells with donors of nitric oxide and peroxynitrite reduced taurine transporter (TauT) expression (by 35 ± 5% and 29 ± 7% respectively p < 0.05 both) as well as the maximum velocity of taurine uptake (TauT Vmax). NOS inhibition prevented glucose-mediated TauT mRNA downregulation, and restored TauT Vmax. These data demonstrate an important role for taurine in the prevention of nitrosative stress in human Schwann cells, which may have important implications for the development and treatment of diabetic neuropathy.

► Effects of high glucose and taurine on RNS, iNOS and nNOS in human Schwann cells. ► Important role for taurine in the prevention of nitrosative stress in HSC cells. ► Mechanism of action which is partially independent of an antioxidant effect. ► Taurine reduces RNS and NOS upregulation in glucose-exposed HSC.